TransMedics (NSDQ:TMDX) posted third-quarter results that beat the consensus forecast on Wall Street. The Andover, Mass.-based company reported losses of -$5.1 million, or -19¢ per share, on sales of $7.1 million for the three months ended Sept. 30, for a sales loss of -1.6% compared with Q3 2019. Earnings per share were -19¢, 10¢ ahead of […]
Wall Street Beat
Accuray ticks up on Street-beating Q1
Accuray (NSDQ:ARAY) shares ticked up today on first-quarter results that came in ahead of the consensus forecast. The Sunnyvale, Calif.-based radiotherapy device maker posted profits of $402,000, breaking even on a per-share basis, on sales of $85.3 million for the three months ended Sept. 30, 2020, for a bottom-line gain from losses of more than -$9.3 […]
BD beats The Street in Q4, posts 2021 guidance
Becton Dickinson (NYSE:BDX) reported Street-beating fourth-quarter financial results and revealed its 2021 fiscal guidance. The Franklin Lakes, N.J.-based company posted profits of $128 million, or 36¢ per share, on sales of $4.8 billion for the three months ended Sept. 30, 2020, for a -21.5% bottom-line slide on sales growth of 4.4%. Adjusted to exclude one-time items, […]
Insulet surpasses Q3 earnings estimates, raises guidance
Insulet (NSDQ:PODD) posted third-quarter results after market close yesterday that beat analysts’ consensus for the company. The Acton, Mass.-based tubeless insulin pump manufacturer announced profits of $11.6 million or $0.17 per share on sales of $234 million for the three months ended September 30, 2020, for a bottom-line gain of 13.5% on sales growth of 21% […]
Axonics beats sales estimates in Q3
Axonics (NSDQ: AXNX) saw its stock tick up by 5.47% at the close of trading on third-quarter results that beat the consensus earnings forecast. The Irvine, Calif.-based sacral neuromodulation technologies company had a -$9.2 million loss, or -$0.24 per share, in the quarter ended September 30, 2020. The consensus estimate for the stock was a loss of […]
Conformis up a bit on Street-beating Q3 report
Conformis (NSDQ:CFMS) shares rose slightly in after-hours trading today on third-quarter results that continued to reflect pandemic-related losses. The Billerica, Mass.-based joint replacement implant maker posted losses of -$6.18 million, or -9¢ per share, on sales of $15.98 million for the three months ended September 30, 2020, for a 28.9% bottom-line gain on a sales decline […]
Surmodics rises on mixed bag Q4
Surmodics (NSDQ:SRDX) shares ticked up to end the day on fourth-quarter results that beat the consensus earnings forecast. The Eden Prairie, Minn.-based in vitro technology developer posted losses of -$2.9 million, or -22¢ per share, on sales of $22.5 million for the three months ended Sept. 30, 2020, for a bottom-line slide into the red on […]
Hologic rises on Street-beating Q4
Hologic (NSDQ:HOLX) shares got a boost today on fourth-quarter results that topped the consensus forecast. The Marlborough, Mass.-based diagnostic company posted profits of $495 million, or $1.88 per share, on sales of $1.35 billion for the three months ended Sept. 26, 2020, for a massive bottom-line gain from the red on sales growth of 55.6%. Adjusted […]
Haemonetics posts Street-beating Q2
Haemonetics (NYSE:HAE) shares dipped slightly on second-quarter results that topped the consensus forecast. The Boston-based blood management technology developer posted profits of $48.1 million, or 94¢ per share, on sales of $209.5 million for the three months ended Sept. 26, 2020, for a 28.3% bottom-line gain on a sales decline of -17.1%. Adjusted to exclude one-time […]
Coloplast sees revenue growth accelerating in 2021, acquires Nine Continents Medical
Coloplast (CPH:COLO-B) announced today that it was able to boost its annual earnings even as the COVID-19 pandemic held down sales growth — with the Danish medical device giant expecting a stronger 2021. Also today, Coloplast announced that it has completed its acquisition of Nine Continents Medical, an early-stage company pioneering an implantable tibial nerve stimulation […]
Bruker slides on Street-beating Q3 results
Bruker Corp. (NSDQ:BRKR) posted third-quarter results that beat the consensus on Wall Street. The Billerica, Mass.-based company reported profits of $54.3 million, or 35¢ per share, on sales of $511.4 million for the three months ended Sept. 30, for a bottom-line loss of -11.4% sales loss of -1.9% compared with Q3 2019. Adjusted to exclude one-time […]
